Corcept Therapeutics reported $30.03M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Ani Pharmaceuticals ANIP:US $ 18.82M 1.23M
Aphria Inc APH:CN C$ 74.04M 19.84M
Ardelyx ARDX:US $ 20.12M 2.99M
Biodelivery Sciences International BDSI:US $ 25.78M 1.98M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Canopy Growth Corp WEED:CN C$ 111.05M 38.77M
Corcept Therapeutics CORT:US $ 30.03M 520K
Depomed DEPO:US $ 26.24M 18.5M
Eleven Biotherapeutics EBIO:US 6.8M 1.51M
Eli Lilly And LLY:US $ 1.69B 109.7M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Johnson & Johnson JNJ:US $ 6.07B 641M
Knight Therapeutics Inc GUD:CN C$ 18.63M 3.94M
Lannett LCI:US $ 21.58M 3.94M
Lexicon Pharmaceuticals LXRX:US 7.94M 321K
Merk MRK:US $ 2.25B 376M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Novartis NOVN:VX 3.71B 190M
Novartis NVS:US 3.71B 190M
Omeros OMER:US $ 21.56M 3.51M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Pfizer PFE:US $ 2.79B 134M
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M
Tg Therapeutics TGTX:US $ 34.02M 7.26M
Ziopharm Oncology ZIOP:US $ 9.07M 842K